Pain is one of the most common experiences reported by people with colorectal cancer, affecting more than 70% of patients at some point during the course of the disease.1PubMed. Management of pain in colorectal cancer patients How much it hurts, when it starts, and what it feels like vary enormously depending on where the tumor sits, how far it has progressed, and what treatments you undergo. For some people, pain is barely noticeable at diagnosis; for others, it is the symptom that finally sends them to a doctor. Understanding what drives that pain and what can be done about it matters at every stage.
Where Colon Cancer Pain Actually Comes From
The pain you feel from a colorectal tumor is not one thing. It arises through several different mechanisms, sometimes layered on top of each other. A growing tumor can press against or invade the tissue around it, triggering what doctors call visceral pain, the deep, crampy, hard-to-pinpoint ache that comes from your internal organs. Tumors can also cause infection or inflammation in surrounding tissue and release chemical signals that sensitize nearby nerves, essentially turning up the volume on pain signals even when the physical damage has not changed much.2PubMed Central. Colorectal cancer pain upon diagnosis and after treatment: a cross-sectional comparison with healthy matched controls
When a tumor grows in the rectum or low in the pelvis, the pain picture can become more complicated. Rectal tumors sometimes spread along nerve pathways, following the pelvic nerves as conduits to reach the lumbosacral plexus, the bundle of nerves that serves your legs and lower back. This kind of perineural spread can produce radiating leg pain, numbness, or weakness that may initially be mistaken for a back problem rather than a cancer symptom.3PubMed Central. Recurrent rectal cancer causing lumbosacral plexopathy with perineural spread to the spinal nerves and the sciatic nerve: an anatomic explanation Rectal tumors can also cause tenesmus, an unpleasant sensation of needing to have a bowel movement even when the rectum is empty. Tenesmus is particularly distressing because it can be constant, and standard painkillers do not always address it well.4PubMed. Management of Malignant Rectal Pain and Tenesmus: A Systematic Review
How Symptoms Differ by Tumor Location
The colon is a long organ, and where along its length a cancer develops shapes the symptoms you notice first. Right-sided colon cancers tend to grow larger before causing obvious problems because the right colon has a wider opening and stool there is still relatively liquid. People with right-sided tumors more often show up with vague symptoms like fatigue, unexplained weight loss, or iron-deficiency anemia from slow blood loss they never saw. These tumors average around 55 mm in diameter at diagnosis, compared to roughly 38 mm for left-sided tumors.5Europe PMC. Right- and left-sided colon cancer – clinical and pathological differences of the disease entity in one organ
Left-sided colon cancers, by contrast, develop where the colon narrows and stool is more formed. They are more likely to cause visible changes in bowel habits, bright red blood in the stool, and cramping abdominal pain. They also more frequently lead to emergencies: left-sided tumors required urgent surgery about twice as often as right-sided ones in one large comparative study.5Europe PMC. Right- and left-sided colon cancer – clinical and pathological differences of the disease entity in one organ The practical takeaway is that colon cancer on the right side can be sneakier. You may feel tired or lose weight before you feel pain, which is part of why right-sided cancers are often caught at a later stage.
Pain and the Stage at Diagnosis
It seems intuitive that a bigger, more advanced cancer would hurt more, and there is some truth to that, but the relationship is not as straightforward as you might expect. Research on symptom patterns has found that visible blood in the stool tends to show up with earlier-stage disease, while abdominal pain and more generalized symptoms like fever or unexplained weight loss are linked to higher-stage tumors.6PubMed. Association of symptoms of colon cancer patients with tumor location and TNM tumor stage In other words, the cancers that cause the most pain tend to be the ones that have progressed further.
A study focused specifically on younger colorectal cancer patients found that nearly all of them, about 95%, had symptoms at diagnosis. The most common were changes in bowel habits, rectal bleeding, and abdominal pain, with pain affecting close to half the group. Interestingly, though, the number and duration of symptoms did not differ much between patients with early-stage and late-stage disease. About 78% of those with stage I or II cancers already had two or more symptoms, compared to roughly 84% of those with stage III or IV.7PubMed Central. Characteristics and Symptomatology of Colorectal Cancer in the Young That narrow gap is a sobering reminder that having “just a little pain” does not reliably mean the cancer is small.
One more detail from that same study stands out: about one in ten younger patients attributed their symptoms to hemorrhoids before receiving a cancer diagnosis.7PubMed Central. Characteristics and Symptomatology of Colorectal Cancer in the Young Rectal bleeding paired with pain is common enough in benign conditions that it can be easy to dismiss, which contributes to delayed diagnoses especially in people under 50.
When Pain Becomes an Emergency
The scenario that makes colon cancer pain suddenly severe is obstruction. When a tumor grows large enough to block the passage of stool and gas through the colon, it produces intense cramping pain, abdominal distension, vomiting, and an inability to pass anything. Roughly 10% to 18% of colon cancer patients first learn about their cancer because they present to an emergency department with an obstruction.8Europe PMC / World Journal of Gastrointestinal Oncology. Management of obstructive colon cancer: Current status, obstacles, and future directions Despite expanded screening programs, this percentage has remained stubbornly stable over time.
Obstruction is a medical emergency. The traditional treatment is emergency surgery, which carries higher complication and death rates compared to planned, elective operations.8Europe PMC / World Journal of Gastrointestinal Oncology. Management of obstructive colon cancer: Current status, obstacles, and future directions One alternative that has gained traction is placing a colonic stent, a small expandable metal tube that props the blocked section open. Stenting can relieve the obstruction without immediate surgery, giving doctors time to plan a safer elective operation later. For patients with advanced cancer who are not candidates for surgery, stenting also serves as an effective long-term palliative measure.9PubMed Central. Colon stenting: a review That said, stents are not risk-free; they can migrate, become re-blocked by tumor growth, or rarely perforate the colon wall.10PubMed. Update on the indications and use of colonic stents
Pain That Treatment Itself Causes
Pain from colon cancer does not end when the tumor is removed or treated. In fact, some of the most persistent pain comes from the treatments themselves.
Chemotherapy-Induced Nerve Damage
Oxaliplatin, one of the backbone drugs in colorectal cancer chemotherapy, is notorious for damaging peripheral nerves. The vast majority of patients experience acute nerve-related symptoms, including heightened sensitivity to cold and touch, after each cycle of treatment.11PubMed. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study In a real-world study of patients who had completed oxaliplatin-based chemotherapy, about 85% reported tingling or numbness in their fingers and hands, and around half had the same in their toes and feet. Over 20% said these neuropathic symptoms came with pain, and close to 30% reported cramping.12PubMed Central. Oxaliplatin-induced neuropathy and colo-rectal cancer patient’s quality of life: Practical lessons from a prospective cross-sectional, real-world study
What makes oxaliplatin neuropathy frustrating is that it can persist long after chemotherapy ends. The tingling and numbness may fade slowly over months or years, but some patients are left with permanent sensory changes. It is one of the most common reasons people have to reduce their chemotherapy dose or stop treatment earlier than planned, which creates a painful trade-off between cancer control and quality of life.
Chronic Pain After Surgery
Surgery is the primary treatment for most non-metastatic colon cancers, and while recovery from bowel surgery has improved with minimally invasive techniques, chronic pain afterward is more common than most people realize. A large population-based study found that about 42% of colorectal cancer survivors reported some level of ongoing pain, with roughly 15% experiencing what the researchers classified as major pain.13PubMed Central. Chronic pain after colorectal cancer treatment: A population-based cross-sectional study Rectal cancer survivors fared slightly worse than colon cancer survivors, likely because pelvic surgery is more complex and involves more nerve-dense tissue.
Several factors made major chronic pain more likely: being younger than 60, being female, having had open rather than minimally invasive surgery, receiving chemotherapy or radiation, having a permanent stoma, and having pre-existing health conditions. Surgical complications like anastomotic leakage, where the reconnected ends of the bowel fail to heal properly, also raised the risk.13PubMed Central. Chronic pain after colorectal cancer treatment: A population-based cross-sectional study Chronic pain after colon surgery is still an area where measurement tools are catching up; researchers have noted the lack of a validated scoring system as a barrier to understanding the problem better.14PubMed. Chronic pain after colon cancer surgery: Translation and validation of a scoring system
Managing Colon Cancer Pain
Pain management in colorectal cancer is not a single prescription. It typically involves layering multiple strategies together, starting with the simplest and escalating as needed. The foundation of cancer pain management has three parts: thorough assessment of the pain, establishing an appropriate medication regimen usually anchored by opioid therapy, and integrating other treatments such as anti-inflammatory drugs, nerve-targeting medications, interventional procedures, and psychological support.15PubMed. Cancer pain management
For mild pain, over-the-counter options like acetaminophen or ibuprofen may be sufficient. As pain increases, doctors step up to opioid medications, starting at lower potency and adjusting upward based on response. The goal is to find a dose that controls pain without intolerable side effects. Many patients worry about opioid dependence, which is an understandable concern, but in the setting of active cancer pain, the medical consensus is that well-managed opioid therapy meaningfully improves quality of life when other options are inadequate.
Chemotherapy-induced neuropathy presents its own management challenge. Despite theoretical reasons to think nerve-stabilizing medications would help, a well-designed clinical trial found that gabapentin, one of the most commonly prescribed drugs for nerve pain, did not outperform a placebo for chemotherapy-induced peripheral neuropathy symptoms.16PubMed. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) That trial focused on general neuropathy symptoms. Gabapentinoids, however, have shown promise in a narrower context: cancer-related tenesmus. In a case series, low-dose gabapentinoids reduced daily pain intensity and discomfort from rectal and bladder tenesmus by roughly two-thirds or more within a few days.17PubMed Central. Effectiveness of Gabapentinoids for Cancer-related Rectal and Vesical Tenesmus: Report of Four Cases The evidence there is still limited to small studies, but for patients suffering from refractory tenesmus who have exhausted other options, the results are encouraging.
Nerve Blocks and Interventional Approaches
When medications alone are not controlling pelvic or abdominal pain, interventional procedures can sometimes make a dramatic difference. One of the most studied is the superior hypogastric plexus block, in which an anesthetic or a chemical agent is injected near the nerve bundle that relays pain signals from the pelvis. An early landmark study found this block was effective in relieving pain in about 69% of cancer patients with chronic pelvic pain.18Pain. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer
A systematic review of the procedure confirmed its general effectiveness and found that it significantly reduced both pain severity and daily opioid requirements. Patients reported meaningful improvements in quality of life and satisfaction after the block. The review also noted, though, that the block tended to fail more often in patients whose cancer had already invaded the retroperitoneal space, and that performing the procedure earlier in the disease course produced better results.19Revista Chilena de Anestesia. Effectiveness of the superior hypogastric plexus neurolytic block in the management of pelvic abdominal pain in adult patients diagnosed with cancer: A systematic literature review The practical message is that if you are struggling with pelvic cancer pain that pills are not controlling, asking about nerve block options sooner rather than later may give them the best chance of working.
How Depression and Anxiety Amplify Pain
Pain is not purely a physical signal. Your emotional state can turn the dial up or down considerably. Research on colorectal cancer patients has found that higher levels of depression and anxiety are tied to greater pain and fatigue, alongside elevated markers of inflammation.20PubMed Central. Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation This is not a polite way of saying the pain is “in your head.” The connection between mood, inflammation, and pain perception is biological. Depression and anxiety alter how your nervous system processes pain signals and can lower your threshold for what registers as painful. Managing mental health is, in a very real sense, part of managing physical pain.
This is one reason comprehensive cancer care teams include psychologists, social workers, or psychiatrists. Cognitive behavioral therapy, medication for depression or anxiety, and peer support groups are not add-ons or luxuries. They are components of pain management.
Acupuncture and Complementary Approaches
Many patients turn to complementary therapies either because standard pain treatment is not enough or because they want to minimize medication side effects. Among these, acupuncture has the most robust evidence in the cancer pain space. A meta-analysis examining acupuncture for cancer-related pain found it produced a moderate overall reduction in pain. Specifically, it was effective for pain caused directly by a tumor and for pain following surgery. It did not, however, show a benefit for pain caused by chemotherapy, radiation, or hormonal therapy.21PubMed. Systematic review and meta-analysis of acupuncture to reduce cancer-related pain
This means acupuncture is most useful as part of a broader plan, not as a replacement for medication. If you are dealing with ongoing tumor-related aching or post-surgical pain, adding acupuncture sessions may give you an incremental benefit. For neuropathy from chemo, the evidence does not support it, and your time and money may be better spent elsewhere.
When Symptoms Get Attributed to Something Else
One of the more insidious aspects of colon cancer pain is how easily it gets blamed on benign conditions, particularly in women. A data-linkage study tracking pre-diagnostic visits found that women had a higher risk of receiving their colon cancer diagnosis through an emergency presentation rather than a planned workup. Part of the explanation was that their symptoms tended to be less specific and were more often attributed to benign diagnoses in the years before cancer was identified. Having a benign diagnosis in the year before cancer detection roughly doubled the odds of an emergency presentation in women. For women aged 40 to 59 who had received a recent benign diagnosis, the odds of emergency presentation were more than four times higher.22PubMed Central. Opportunities for reducing emergency diagnoses of colon cancer in women and men: A data-linkage study on pre-diagnostic symptomatic presentations and benign diagnoses
The clinical lesson here is straightforward. Abdominal pain, bloating, fatigue, and changes in bowel habits in women are frequently chalked up to irritable bowel syndrome, gynecological issues, or stress. If these symptoms persist or worsen, pushing for further investigation, including colonoscopy, is reasonable regardless of age.
Gender Differences in Pain Experience
Beyond diagnostic delays, there are measurable differences in how men and women experience pain and quality of life during and after colorectal cancer treatment. Women with colorectal cancer report higher mean pain scores and greater fatigue compared to men.23PubMed Central. Gender differences in health-related quality of life among patients with colorectal cancer A separate study examining quality of life during chemotherapy found that both men and women scored lower than healthy controls across the board, but the drop was more pronounced in women. Men, meanwhile, reported more limitations in work and daily activities tied to their emotional response to the diagnosis, suggesting the burden shows up differently between the sexes.24PubMed. The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women
How much of this difference is biological versus cultural is hard to untangle. One study tried to parse out whether the quality-of-life gaps between men and women with colorectal cancer were truly disease-specific or just reflected sex-based differences that exist in the general population. The analysis found that for most quality-of-life measures, the gap between men and women was about the same in cancer patients as in healthy controls. The only cancer-specific gender difference they could isolate was in diarrhea symptoms.25PubMed. Are gender-associated differences in quality of life in colorectal cancer patients disease-specific? That finding suggests women do not necessarily experience colorectal cancer as a uniquely worse pain condition than men do. Rather, the baseline pain and fatigue differences between sexes carry through into the cancer experience. It also means that existing tools for measuring cancer quality of life should be interpreted with baseline gender norms in mind rather than assuming any gap reflects how the cancer is being treated.
What Pain Feels Like at Each Phase
Pulling the threads together, the pain of colon cancer is not static. It shifts in character and intensity across the arc of the disease. Before diagnosis, many people have vague or intermittent symptoms: belly cramps that come and go, unexplained tiredness, a change in how often or how easily they have bowel movements. These symptoms can persist for months before anyone suspects cancer. A newly diagnosed patient may already have lower pain thresholds than a healthy person, measurable through pressure testing.2PubMed Central. Colorectal cancer pain upon diagnosis and after treatment: a cross-sectional comparison with healthy matched controls
During active treatment, pain often intensifies. Surgery causes acute post-operative pain that normally improves within weeks, but chemotherapy-induced neuropathy builds cycle by cycle, and radiation to the pelvis can cause its own inflammatory pain and tissue damage. After treatment ends, some patients recover well. Others enter a prolonged period of chronic pain from nerve damage, surgical adhesions, or altered bowel function. The same study that measured pain thresholds found that post-treatment patients actually showed even more marked differences from healthy controls than newly diagnosed patients did, with lower muscle mass and greater sensitivity to pressure.2PubMed Central. Colorectal cancer pain upon diagnosis and after treatment: a cross-sectional comparison with healthy matched controls
For people with advanced or metastatic disease, pain management becomes an ongoing negotiation between symptom control and side effects. The combination of tumor burden, treatment toxicity, and psychosocial distress means that advanced colorectal cancer pain is best managed by a team, not a single doctor writing a single prescription. Palliative care specialists, who focus specifically on symptom relief and quality of life regardless of prognosis, are an underused resource. Many patients and families associate palliative care with end-of-life decisions, but early referral to palliative care has been shown across multiple cancer types to improve both comfort and outcomes. If you or someone you know is dealing with colorectal cancer pain that is not well controlled, requesting a palliative care consultation is one of the most effective steps available.